Red Sox right-hander Clay Buchholz is hopeful that he’ll be able to pitch again this season after a follow-up visit to Dr. James Andrews.
About three weeks ago Dr. Andrews advised Buchholz to avoid surgery for his injured elbow and instead gave him a platelet-rich plasma injection, which has worked well enough for him to resume throwing.
Buchholz hasn’t pitched since July 10, so he’ll have to build back his arm strength while also avoiding any setbacks–some pitchers still need surgery after initially trying platelet-rich plasma injections–but September action with the Red Sox is now possible.
And that could prove key, because the Red Sox hold a $13 million team option for 2016 on Buchholz, who had a 3.26 ERA and 107/23 K/BB ratio in 113 innings before being shut down.
Former Angels outfielder Jabari Blash has signed a one-year deal with the Tohoku Rakuten Golden Eagles of Nippon Professional Baseball, the team announced Friday. Per the Japan Times, the deal is said to be worth around $1.06 million. Blash was released from his contract with the Angels at the end of November.
The 29-year-old outfielder has had a rough go of it in the majors, where he failed to duplicate the promising results he delivered in the minors. While he consistently batted above .250 with 20-30 home runs per season at the Double- and Triple-A level, he petered out in back-to-back gigs with the Padres and Angels and slumped toward a .103/.200/.128 finish across 45 PA for Anaheim in 2018.
The hope, of course, is that the environment in NPB will help him get a better handle on his issues at the plate — in a best case scenario, resulting in a full-scale transformation that could make him more marketable to MLB teams in the future. To that end, Blash expects to be utilized as a cleanup batter in the Eagles’ lineup and will focus on assisting the club as they make a run toward the Japan Series.